Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.
| Analyst | Firm | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Olivia Tong | Raymond James | 9 questions · 0% challenging |
| Chris Carey | Wells Fargo | 9 questions · 11% challenging |
| Steve Powers | Deutsche Bank | 9 questions · 22% challenging |
| Rob Moskow | TD Cowen | 9 questions · 22% challenging |
| Dara Mohsenian | Morgan Stanley | 9 questions · 0% challenging |
| Kaumil Gajrawala | Jefferies | 9 questions · 0% challenging |
| Rob Ottenstein | Evercore ISI | 9 questions · 11% challenging |
| Lauren Lieberman | Barclays | 8 questions · 38% challenging |
| Peter Grom | UBS | 8 questions · 13% challenging |
| Andrea Teixeira | JPMorgan | 8 questions · 0% challenging |
| Firm | Analysts | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| TD Cowen | 1 analyst | 9 questions · 22% challenging |
| Wells Fargo | 1 analyst | 9 questions · 11% challenging |
| Morgan Stanley | 1 analyst | 9 questions · 0% challenging |
| Raymond James | 1 analyst | 9 questions · 0% challenging |
| Deutsche Bank | 1 analyst | 9 questions · 22% challenging |
| Evercore ISI | 1 analyst | 9 questions · 11% challenging |
| Jefferies | 1 analyst | 9 questions · 0% challenging |
| Bank of America | 2 analysts | 8 questions · 0% challenging |
Procter & Gamble delivered Q3 FY26 with organic sales increasing more than 3% and core EPS of $1.59, up 3% on a currency-neutral basis. Broad-based organic sales acceleration reflected innovation-driven volume recovery. China grew in a challenging market. Middle East conflict costs created headwinds, compressing core gross margin by 100 basis points and operating margin by 80 basis points. FY2026 guidance was maintained at in-line to +4% for organic sales and core EPS, with management expecting the lower end due to geopolitical costs.
Demand | Competitive Dynamics | Pricing | Innovation & R&D | Cost Pressure | Geographic Expansion | Guidance Reliability | Margin | |
|---|---|---|---|---|---|---|---|---|
| 2025Q1 | 10 | 5 | 2 | 2 | 2 | 1 | 4 | 1 |
| 2025Q2 | 7 | 2 | 4 | 4 | 1 | 3 | 2 | 2 |
| 2025Q3 | 7 | 3 | 2 | 2 | 2 | 3 | 3 | |
| 2025Q4 | 4 | 2 | 4 | 3 | 2 | 2 | 2 | |
| 2026Q1 | 4 | 4 | 3 | 3 | 2 | 6 | ||
| 2026Q2 | 6 | 4 | 3 | 4 | 3 | 1 | 1 | 4 |
| 2026Q3 | 6 | 7 | 5 | 2 | 7 | 2 | 2 | 2 |
| '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | '26Q2 | '26Q3 | |
|---|---|---|---|---|---|---|---|
| Demand | 10 | 7 | 7 | 4 | 4 | 6 | 6 |
| Competitive Dynamics | 5 | 2 | 3 | 2 | 4 | 4 | 7 |
| Pricing | 2 | 4 | 2 | 4 | 3 | 3 | 5 |
| Innovation & R&D | 2 | 4 | 2 | 3 | 3 | 4 | 2 |
| Cost Pressure | 2 | 1 | 2 | 2 | 2 | 3 | 7 |
| Geographic Expansion | 1 | 3 | 3 | 2 | 6 | 1 | 2 |
| Guidance Reliability | 4 | 2 | 3 | 2 | 1 | 2 | |
| Margin | 1 | 2 | 4 | 2 |
On July 29, 2026, Procter & Gamble announced that Shailesh Jejurikar, President and Chief Executive Officer, was appointed Chairman of the Board effective August 1, 2026, holding the role in addition to his existing position. Executive Chairman Jon Moeller will retire from the board effective July 31, 2026, and from the company effective August 14, 2026, after 38 years of service that included the Executive Chairman, CEO, COO, and CFO roles.
What each event means for PG’s sentiment score is part of Tellvest Pro.
Calendar quarter Q1 2026Earnings call Apr 24, 2026
FY2026 Q3 in brief
Procter & Gamble delivered Q3 FY26 with organic sales increasing more than 3% and core EPS of $1.59, up 3% on a currency-neutral basis.
Newest quarter FY2026 Q4 is part of Pro · see what Pro adds →
Sources. Tellvest earnings-call sentiment score for The Procter & Gamble Company (PG), FY2026 Q3: 5/10. Scores: The Procter & Gamble Company’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: PG daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2025 Q1 | $21.74B | -0.6% | $1.61 | -12.0% | 26.7% | 18.2% | $3.31B |
| FY2025 Q2 | $21.88B | +2.1% | $1.88 | +34.3% | 26.2% | 21.2% | $3.90B |
| FY2025 Q3 | $19.78B | -2.1% | $1.54 | +1.3% | 23.0% | 19.1% | $2.85B |
| FY2025 Q4 | $20.89B | +1.7% | $1.48 | +16.5% | 20.8% | 17.3% | $3.99B |
| FY2026 Q1 | $22.39B | +3.0% | $1.95 | +21.1% | 26.2% | 21.2% | $4.21B |
| FY2026 Q2 | $22.21B | +1.5% | $1.78 | -5.3% | 24.2% | 19.5% | $3.81B |
| FY2026 Q3Selected | $21.23B | +7.4% | $1.63 | +5.8% | 21.5% | 18.7% | $3.03B |
| FY2026 Q4 | $21.20B | +1.5% | $1.26 | -14.9% | 18.6% | 14.1% | $4.87B |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
GAAP revenue YoY +7.38% → base 6. The base score is anchored to the GAAP revenue YoY band before transcript, EPS, and guidance adjustments.
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
PG The Procter & Gamble Company | 5 | +7.4% | |
| CHD Church & Dwight | 6 | +0.1% | |
| CL Colgate-Palmolive | 7 | +8.4% | |
| CLX Clorox | 4 | +0.1% | |
| EL Estée Lauder Companies (The) | 9 | +4.6% | |
| KMB Kimberly-Clark | 5 | -14.0% | |
| KVUE Kenvue | 6 | +4.5% |